Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest uterine fibroid Stories

2013-04-18 08:32:50

TIRAT CARMEL, Israel, April 18, 2013 /PRNewswire/ -- InSightec Ltd. announced today that the US Centers for Medicare & Medicaid Services (CMS), a federal agency within the US Department of Health and Human Services (HHS), has created a new billing code for MR guided focused ultrasound treatment of pain palliation of metastatic bone lesions and has established a Medicare payment rate for hospital outpatient departments. InSightec's ExAblate received Food and Drug...

2013-04-15 19:20:49

Women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D, according to a study from researchers at the National Institutes of Health. Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus. Fibroids often result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States. The study of 1,036 women, aged 35-49, living in the Washington,...

2013-04-15 19:14:19

Giving men 'prostate of their youth;' prostatic artery embolization provides relief from frustrating urinary symptoms, helps men avoid surgery, say researchers Men with a common condition that causes frequent nighttime trips to the bathroom can get relief with a minimally invasive treatment that shrinks the prostate, suggests a study being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. The early findings hail from the first prospective...

2013-04-15 12:27:48

Giving men "prostate of their youth"; prostatic artery embolization provides relief from frustrating urinary symptoms, helps men avoid surgery, say researchers NEW ORLEANS, April 15, 2013 /PRNewswire-USNewswire/ -- Highlights Prostate artery embolization (PAE) shrinks enlarged prostates, giving men relief from frequent urination and other symptoms, suggest early results of the first prospective U.S. study. 92 percent of men who had PAE experienced a significant decrease in their...

2013-04-03 23:01:05

Fibroids Miracle is a new fibroids treatment method designed by Amanda Leto, who promises to help people get rid of fibroids permanently and naturally. A full Fibroids Miracle review on the site Vkool.com shows whether or not the method is safe for patients to follow. Seattle, Wa (PRWEB) April 03, 2013 Fibroids Miracle is a brand new fibroids treatment method created by Amanda Leto, who claims to help sufferers get rid of uterine fibroids quickly. This program does not contain supplements,...

2013-04-01 04:20:29

LIVERMORE, Calif., April 1, 2013 /PRNewswire/ -- Halt Medical, Inc. announced today initial commercialization results for the Acessa System and additional launch plans. "We are grateful and encouraged that virtually all our clinical trial sites expressed an interest in launching the Acessa Procedure. As of this past week, all four of our initial launch sites have purchased and performed procedures," said Jeffrey M. Cohen, Halt Medical CEO. He added, "This is testimony to the proven value of...

2013-03-27 08:31:25

STUDY WILL EVALUATE SIX MONTHS OF TREATMENT IN 280 SUBJECTS SAN DIEGO, March 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated. Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist, in development by AbbVie for the treatment of uterine fibroids and endometriosis. Neurocrine and AbbVie entered into a collaboration and license...

2013-03-12 04:21:12

LIVERMORE, Calif., March 12, 2013 /PRNewswire/ -- Halt Medical, Inc. announced that Dr. Jay M. Berman, M.D., FACOG, has performed the first commercial Acessa Procedure in the United States. The procedure is used for the treatment of uterine fibroids. Dr. Berman performed the procedure at the Berry Surgery Center in Farmington Hills, MI, an outpatient facility affiliated with the Detroit Medical Center's DMC Sinai-Grace Hospital. "We are extremely happy that Dr. Berman, the Wayne State...

2013-02-27 12:27:11

Live Audio Webcast Wednesday, March 6, 2013 SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be presenting at the Cowen and Company 33(rd) Annual Health Care Conference in Boston. The live presentation takes place on Wednesday, March 6 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time. The presentation will be webcast and may be accessed on the...

2013-02-11 04:20:39

LIVERMORE, Calif., Feb. 11, 2013 /PRNewswire/ -- Halt Medical, Inc. announced today that on January 18, 2013, COFEPRIS, a division within the Mexican Ministry of Health (Secretaria de Salud) responsible for medical device oversight, issued registration for the Acessa System to treat symptomatic uterine fibroids. "Mexico is the second largest market for medical devices in Latin America," said Jeffrey Cohen, Halt's Chief Executive Officer. "We are very excited to have the opportunity to expand...